The PCPT trial

The PCPT trial

他のバージョン（2件）を表示する

The PCPT trial is the first phase III trial with the principal objective of examining the hypothesis that the use of chemoprevention could prevent the development of prostate cancer. This is a large scale randomised clinical trial comparing finasteride (5-α reductase inhibitor) to placebo. A total o...

書誌詳細
主要な著者:	Hamdy, F, Rouprêt, M
フォーマット:	Journal article
言語:	French
出版事項:	2008

類似資料

[The PCPT trial].
著者:: Hamdy, F, 等
出版事項: (2008)

The PCPT trial
著者:: Hamdy, F, 等
出版事項: (2008)

Estimating Hydraulic Conductivity of Overconsolidated Soils Based on Piezocone Penetration Test (PCPT)
著者:: Binyam M. Bekele, 等
出版事項: (2021-02-01)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT)/
著者:: 207490 Ismail Bakar, 等
出版事項: (1981)

Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative Group.
著者:: Ankerst, D, 等
出版事項: (2012)

In-situ determination of soil compressibility using piezometer cone penetration testing (PCPT) / [mikrofilem]
著者:: 207490 Ismail Bakar

A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort
著者:: Samuel Carbunaru, 等
出版事項: (2019-11-01)

Time-dependent behavior of full-scale precast post-tensioned (PCPT) girders: Experimental and finite element analysis
著者:: Panuwat Joyklad, 等
出版事項: (2022-12-01)

Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
著者:: Enrique Gomez Gomez, 等
出版事項: (2019-11-01)

Correction: Observational study comparing the accuracy/variability between the ERSPC and the PCPT risk calculators for the prediction of significant prostate cancer in patients with PSA
出版事項: (2020-02-01)

Prostate cancer risk calculators – PBCG vs. PCPT 2.0: Which one should we use when it comes to clinical decision-making?
著者:: A.B. Silva, 等
出版事項: (2020-11-01)

PROSTATE CANCER RISK CALCULATOR COMPARISON: IPCRC vs KPCRC vs PCPT-RC vs ERSPC-RC IN PREDICTING PROSTATE CANCER AT HASAN SADIKIN HOSPITAL
著者:: Christiano Tansol, 等
出版事項: (2017-07-01)

Becoming editor-in-chief of European Urology Oncology: The 4 pillars of the development strategy
著者:: M. Rouprêt
出版事項: (2023-11-01)

Transurethral resection biopsy as part of a saturation biopsy protocol: a cohort study and review of the literature.
著者:: Yates, DR, 等
出版事項: (2013)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
著者:: Rouprêt, M, 等
出版事項: (2005)

The prostate cancer prevention trial and its messages.
著者:: Hamdy, F
出版事項: (2007)

Clinically localised prostate cancer is microsatellite stable.
著者:: Azzouzi, A, 等
出版事項: (2007)

Word of wisdom. Re: mortality results from the Goteborg randomised population-based prostate-cancer screening trial.
著者:: Hamdy, F
出版事項: (2010)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression.
著者:: Rouprêt, M, 等
出版事項: (2008)

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression
著者:: Roupret, M, 等
出版事項: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
著者:: Roupret, M, 等
出版事項: (2007)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
著者:: Hamdy, F, 等
出版事項: (2003)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
著者:: Elisabeth Grobet-Jeandin, 等
出版事項: (2021-10-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
著者:: Roupret, M, 等
出版事項: (2004)

A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis.
著者:: Rouprêt, M, 等
出版事項: (2008)

Compared performance of microsatellite and methylation urinalysis in predicting recurrence in transitional cell carcinoma and definition of a diagnostic panel of markers by bayesian network analysis
著者:: Roupret, M, 等
出版事項: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
著者:: Elliott, D, 等
出版事項: (2017)

Robot-assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: A pilot single-center study
著者:: E. Chartier-Kastler, 等
出版事項: (2020-07-01)

Addressing patient treatment preferences at trial recruitment.
著者:: Mills, N, 等
出版事項: (2011)

THE PROTECT TRIAL - EVALUATING THE EFFECTIVENESS OF TREATMENTS FOR CLINICALLY LOCALISED PROSTATE CANCER
著者:: Lane, J, 等
出版事項: (2009)

[Early diagnosis and surgical management of prostate cancer]
著者:: Linton, D, 等
出版事項: (2004)

Early diagnosis and surgical management of prostate cancer
著者:: Linton, D, 等
出版事項: (2004)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
著者:: Donovan, J, 等
出版事項: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
著者:: Lane, J, 等
出版事項: (2007)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
著者:: Mills, N, 等
出版事項: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
著者:: Mills, N, 等
出版事項: (2011)

Perceptions of equipoise are crucial to trial participation: a qualitative study of men in the ProtecT study.
著者:: Mills, N, 等
出版事項: (2003)

Clinical Trial Protocol for PERFECT: A Randomised Controlled Trial Comparing the Efficiency and Tolerance of Transperineal Fusion Versus Transrectal Imaging-targeted Prostate Biopsies (CCAFU-PR1 Study)
著者:: Alae Touzani, 等
出版事項: (2022-11-01)

The ProtecT trial - Evaluating the effectiveness of treatment for clinically localised prostate cancer (ISRCTN20141297)
著者:: Lane, J, 等
出版事項: (2004)

In defense of randomized clinical trials in surgery: Let us not forget Archie Cochrane's legacy.
著者:: Catto, J, 等
出版事項: (2017)